Inventor

KANNT AIMO

DE9 patents

⚠️ This page may combine multiple inventors who share the name “KANNT AIMO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANOFI SA

3 patents

US8686150B2Apr 1, 2014

6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

SANOFI SA3 citations57

US9133181B2Sep 15, 2015

Substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors

SANOFI SA1 citations47

US11352405B2Jun 7, 2022

GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis

SANOFI SA0 citations45

PLETTENBURG OLIVER

3 patents

US8722671B2May 13, 2014

Isoquinoline derivatives

PLETTENBURG OLIVER0 citations48

US8501736B2Aug 6, 2013

Isoquinoline derivatives

PLETTENBURG OLIVER0 citations48

US8710228B2Apr 29, 2014

Cycloalkylamine substituted isoquinoline derivatives

PLETTENBURG OLIVER0 citations37

SANOFI AVENTIS DEUTSCHLAND

2 patents

US7279286B2Oct 9, 2007

High-throughput-assay with high sensitivity for measuring of the activity of β-adrenergic receptor kinase and for determining the impact of test substances on such activity

SANOFI AVENTIS DEUTSCHLAND23 citations86

US7732151B2Jun 8, 2010

Use of IRS-polypeptides for identifying of pharmaceutically active compounds

SANOFI AVENTIS DEUTSCHLAND1 citations48

LOEHN MATTHIAS

1 patent

US8846712B2Sep 30, 2014

6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

LOEHN MATTHIAS2 citations51